Vertex Pharmaceuticals Inc (VRTX)
400.09
-2.09
(-0.52%)
USD |
NASDAQ |
May 02, 16:00
395.53
-4.56
(-1.14%)
After-Hours: 20:00
Vertex Pharmaceuticals Cash from Operations (Quarterly): 234.60M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 234.60M |
| September 30, 2023 | 1.268B |
| June 30, 2023 | 1.134B |
| March 31, 2023 | 899.90M |
| December 31, 2022 | 1.078B |
| September 30, 2022 | 955.50M |
| June 30, 2022 | 1.140B |
| March 31, 2022 | 956.20M |
| December 31, 2021 | 995.00M |
| September 30, 2021 | 927.20M |
| June 30, 2021 | -199.70M |
| March 31, 2021 | 921.00M |
| December 31, 2020 | 491.53M |
| September 30, 2020 | 907.75M |
| June 30, 2020 | 1.039B |
| March 31, 2020 | 815.70M |
| December 31, 2019 | 445.98M |
| September 30, 2019 | 334.79M |
| June 30, 2019 | 463.75M |
| March 31, 2019 | 324.78M |
| December 31, 2018 | 314.58M |
| September 30, 2018 | 381.35M |
| June 30, 2018 | 321.70M |
| March 31, 2018 | 252.66M |
| December 31, 2017 | 227.51M |
| Date | Value |
|---|---|
| September 30, 2017 | 170.09M |
| June 30, 2017 | 181.65M |
| March 31, 2017 | 265.69M |
| December 31, 2016 | 144.72M |
| September 30, 2016 | 65.66M |
| June 30, 2016 | 40.86M |
| March 31, 2016 | -15.14M |
| December 31, 2015 | 29.14M |
| September 30, 2015 | -62.07M |
| June 30, 2015 | -110.27M |
| March 31, 2015 | -222.24M |
| December 31, 2014 | -181.78M |
| September 30, 2014 | -87.65M |
| June 30, 2014 | -127.92M |
| March 31, 2014 | -175.76M |
| December 31, 2013 | 19.76M |
| September 30, 2013 | -13.72M |
| June 30, 2013 | -0.927M |
| March 31, 2013 | -65.78M |
| December 31, 2012 | 40.56M |
| September 30, 2012 | 105.96M |
| June 30, 2012 | 118.40M |
| March 31, 2012 | 2.916M |
| December 31, 2011 | 503.66M |
| September 30, 2011 | 42.90M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-199.70M
Minimum
Jun 2021
1.268B
Maximum
Sep 2023
779.41M
Average
921.00M
Median
Mar 2021
Cash from Operations (Quarterly) Benchmarks
| Amgen Inc | 538.00M |
| Eli Lilly and Co | 1.166B |
| Regeneron Pharmaceuticals Inc | 1.090B |
| Alpine Immune Sciences Inc | -18.97M |
| Moderna Inc | 622.00M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -886.50M |
| Cash from Financing (Quarterly) | -119.80M |
| Free Cash Flow | 3.279B |
| Free Cash Flow Per Share (Quarterly) | 0.4544 |
| Free Cash Flow to Equity (Quarterly) | 118.50M |
| Free Cash Flow to Firm (Quarterly) | 118.50M |
| Free Cash Flow Yield | 3.15% |